Foghorn Therapeutics Inc (FHTX)

Apr 05, 2026

Strength seen in Dianthus Therapeutics, Inc. (DNTH): Can its 5.6% jump turn into more strength? - MSN

Apr 05, 2026

Apr 05, 2026

FHTX PE Ratio & Valuation, Is FHTX Overvalued - Intellectia AI

Apr 05, 2026

Apr 05, 2026

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - marketbeat.com

Apr 05, 2026

Apr 04, 2026

If You Invested $1,000 in Foghorn Therapeutics Inc. (FHTX) - stocktitan.net

Apr 04, 2026

Apr 02, 2026

FHTX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 02, 2026

FHTX Stock Price, Quote & Chart | FOGHORN THERAPEUTICS INC (NASDAQ:FHTX) - ChartMill

Apr 02, 2026

Apr 01, 2026

Strength Observed in Dianthus Therapeutics, Inc. (DNTH): Will Its 5.6% Increase Lead to Further Gains? - Bitget

Apr 01, 2026

Apr 01, 2026

Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength? - Yahoo! Finance Canada

Apr 01, 2026

Mar 31, 2026

FHTX Should I Buy - Intellectia AI

Mar 31, 2026

Mar 30, 2026

Aug Final Week: Can Foghorn Therapeutics Inc weather a recessionCPI Data & High Conviction Investment Ideas - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Setup Watch: Is Foghorn Therapeutics Inc part of any major index2026 Price Action Summary & Consistent Profit Trading Strategies - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Contrasting Foghorn Therapeutics (NASDAQ:FHTX) and Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

Mar 29, 2026

Mar 28, 2026

Fundamentals Check: Is Foghorn Therapeutics Inc stock a good dividend stock2026 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn

Mar 28, 2026

Mar 20, 2026

Ideas Watch: Is Foghorn Therapeutics Inc stock a hidden gem2026 Fundamental Recap & Safe Entry Point Identification - baoquankhu1.vn

Mar 20, 2026

Mar 17, 2026

Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress By Investing.com - Investing.com Canada

Mar 17, 2026

Mar 16, 2026

What is HC Wainwright's Forecast for FHTX FY2026 Earnings? - MarketBeat

Mar 16, 2026

Mar 15, 2026

Foghorn Therapeutics’ (FHTX) Outperform Rating Reiterated at Wedbush - Defense World

Mar 15, 2026

Mar 14, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Downgraded to Hold Rating by Wall Street Zen - MarketBeat

Mar 14, 2026

Mar 14, 2026

FY2030 Earnings Estimate for FHTX Issued By HC Wainwright - Defense World

Mar 14, 2026

Mar 13, 2026

Brokers Offer Predictions for FHTX FY2030 Earnings - MarketBeat

Mar 13, 2026

Mar 13, 2026

Foghorn Therapeutics (FHTX) Receives a Buy from Guggenheim - The Globe and Mail

Mar 13, 2026

Mar 13, 2026

Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX), RegenXBio (RGNX) and Foghorn Therapeutics (FHTX) - The Globe and Mail

Mar 13, 2026

Mar 13, 2026

Foghorn Therapeutics (FHTX) FY 2025 Losses Reinforce Bearish Unprofitability Narrative - Sahm

Mar 13, 2026

Mar 12, 2026

Jefferies reiterates Foghorn Therapeutics stock rating on pipeline data By Investing.com - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Jefferies reiterates Foghorn Therapeutics stock rating on pipeline data - Investing.com India

Mar 12, 2026

Mar 12, 2026

Foghorn Therapeutics reports $158.9M cash position, extends runway - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Earns "Outperform" Rating from Wedbush - MarketBeat

Mar 12, 2026

Mar 12, 2026

Stifel reiterates Foghorn Therapeutics stock rating at buy By Investing.com - Investing.com Australia

Mar 12, 2026

Mar 12, 2026

Stifel reiterates Foghorn Therapeutics stock rating at buy - Investing.com

Mar 12, 2026

Mar 12, 2026

Foghorn Therapeutics: Pioneering Precision Oncology with Chromatin Regulatory System Targeting and Gene Traffic Control Platform - Minichart

Mar 12, 2026

Mar 11, 2026

Foghorn Advances FHD-909 Trial and Strengthens Financial Position - TipRanks

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook - Bitget

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Inc. (FHTX) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics 10-K: $30.9M revenue, $(1.18) EPS - TradingView

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics (FHTX) maps chromatin-targeting cancer pipeline with Lilly - Stock Titan

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics (NASDAQ: FHTX) narrows 2025 loss and extends cash runway into 2028 - Stock Titan

Mar 11, 2026

Mar 11, 2026

Cancer drug developer Foghorn raises $50M, funds work on hard-to-treat tumors - Stock Titan

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Mar 11, 2026

Mar 11, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Given Buy Rating at HC Wainwright - Defense World

Mar 11, 2026

Mar 10, 2026

HC Wainwright Reiterates Buy Rating for Foghorn Therapeutics (NASDAQ:FHTX) - MarketBeat

Mar 10, 2026

Mar 10, 2026

HC Wainwright Reiterates Buy Rating for Foghorn Therapeutics (FH - GuruFocus

Mar 10, 2026

Mar 08, 2026

Aug Volume: Is Foghorn Therapeutics Inc part of any major index2026 Action & Low Volatility Stock Recommendations - baoquankhu1.vn

Mar 08, 2026

Mar 08, 2026

Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates - MSN

Mar 08, 2026

Mar 07, 2026

Will Foghorn Therapeutics Inc. stock benefit from AI adoptionForecast Cut & Smart Investment Allocation Insights - Naître et grandir

Mar 07, 2026

Mar 06, 2026

Foghorn Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Mar 06, 2026

Mar 04, 2026

FHTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026

Mar 03, 2026

TD Cowen Health Care Conference - marketscreener.com

Mar 03, 2026